Axcelis Technologies, Inc.

Axcelis Technologies, Inc.(ACLS)股票分析

$118.610

-5.954 (-5.02%)收盘时

Loading chart…
最高
124.215
开盘
120.700
成交量加权均价
120.31
成交量
264.12K
市值
4.54B
最低
118.090
成交额
31.77M
企业价值/息税折旧摊销前利润(TTM)
34.52

Axcelis Technologies, Inc. is primarily a producer of ion implantation equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The Company is focused on developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the enabling steps in the IC manufacturing process. The Company's products include High Current, Medium Energy, High Energy, Mid Current, and GSD Ovation. The Company's Purion H6 next generation high current ion implanters deliver process control by leveraging its spot beam architecture, optimized for the full spectrum of high-current applications. The Company's Purion H200 is its state-of-the-art single wafer high current medium energy implanter. Its Purion XE Series high energy ion implanters use RF Linear Accelerator (LINAC) technology. The Company's Purion M ion implanters offer the broadest spectrum of mid-current doses available.

AI 分析 of Axcelis Technologies, Inc. (ACLS)

持有

Axcelis Technologies Inc is currently a hold. The stock is priced at $134.71, which is below the higher analyst target of $198 from B. Riley, indicating potential upside. However, the recent 5-day change of -8.84% and insider selling activity increasing by 2536.94% raise concerns about short-term performance. The forward P/E ratio of 19.84 suggests reasonable valuation, but the downgrade from Craig-Hallum indicates caution in the near term.

估值指标

Axcelis Technologies, Inc.(ACLS)当前预期市盈率为 19.84,5 年平均预期市盈率为 19.77。

预期市盈率

合理
5 年均值 P/E
19.77
当前P/E
19.84
高估
26.79
低估
12.74

预期 EV/EBITDA

高估
5 年均值 EV/EBITDA
18.05
当前EV/EBITDA
34.52
高估
34.38
低估
1.73

预期市销率

合理
5 年均值 P/S
3.29
当前P/S
3.99
高估
4.23
低估
2.35

Alphio AI 对 ACLS 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%ACLS

$45.27

情景价格

基

基准

基准 · 50%ACLS

$41.15

情景价格

悲

悲观

悲观 · 25%ACLS

$27.78

情景价格

持有 ACLS 的大户

W

Weiss Asset Management, LLC

+ 持有ACLS

-2.32%

3个月收益率

事件时间线

2026-09-08 (ET)

08:30:00

Axcelis to Invest $35M in New Manufacturing Facility

2026-08-06 (ET)

07:30:00

Sees Q3 Revenue at $230M, Consensus $214.77M

07:30:00

Q2 Revenue Reaches $215.2M, Exceeds Expectations

2026-07-02 (ET)

12:30:00

Axcelis Stock Drops 15.1% to $151.35

2026-06-09 (ET)

10:10:00

Axcelis Stock Rises 17.6%

资讯

ACLS 常见问题 —— 由 Alphio AI 解答

Axcelis Technologies, Inc. is primarily a producer of ion implantation equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The Company is focused on developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the enabling steps in the IC manufacturing process. The Company's products include High Current, Medium Energy, High Energy, Mid Current, and GSD Ovation. The Company's Purion H6 next generation high current ion implanters deliver process control by leveraging its spot beam architecture, optimized for the full spectrum of high-current applications. The Company's Purion H200 is its state-of-the-art single wafer high current medium energy implanter. Its Purion XE Series high energy ion implanters use RF Linear Accelerator (LINAC) technology. The Company's Purion M ion implanters offer the broadest spectrum of mid-current doses available. It operates in the Technology sector (SPECIAL INDUSTRY MACHINERY, NEC industry).

Axcelis Technologies Inc is currently a hold. The stock is priced at $134.71, which is below the higher analyst target of $198 from B. Riley, indicating potential upside. However, the recent 5-day change of -8.84% and insider selling activity increasing by 2536.94% raise concerns about short-term performance. The forward P/E ratio of 19.84 suggests reasonable valuation, but the downgrade from Craig-Hallum indicates caution in the near term.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易